Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. More Details
No risks detected for OFIX from our risk checks.
Excellent balance sheet and fair value.
Share Price & News
How has Orthofix Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: OFIX has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: OFIX underperformed the US Medical Equipment industry which returned 15.4% over the past year.
Return vs Market: OFIX underperformed the US Market which returned 13.6% over the past year.
Price Volatility Vs. Market
How volatile is Orthofix Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StOrthofix Medical Inc.'s (NASDAQ:OFIX) Intrinsic Value Is Potentially 80% Above Its Share Price
1 month ago | Simply Wall StIs Orthofix Medical (NASDAQ:OFIX) A Risky Investment?
1 month ago | Simply Wall StHave Insiders Been Buying Orthofix Medical Inc. (NASDAQ:OFIX) Shares This Year?
Is Orthofix Medical undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OFIX ($29.85) is trading below our estimate of fair value ($51.93)
Significantly Below Fair Value: OFIX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OFIX is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: OFIX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OFIX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OFIX is good value based on its PB Ratio (1.7x) compared to the US Medical Equipment industry average (3.9x).
How is Orthofix Medical forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OFIX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: OFIX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OFIX's is expected to become profitable in the next 3 years.
Revenue vs Market: OFIX's revenue (8.3% per year) is forecast to grow slower than the US market (9.7% per year).
High Growth Revenue: OFIX's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OFIX's Return on Equity is forecast to be low in 3 years time (5.5%).
How has Orthofix Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OFIX is currently unprofitable.
Growing Profit Margin: OFIX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: OFIX is unprofitable, and losses have increased over the past 5 years at a rate of 22.4% per year.
Accelerating Growth: Unable to compare OFIX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OFIX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).
Return on Equity
High ROE: OFIX has a negative Return on Equity (-6.25%), as it is currently unprofitable.
How is Orthofix Medical's financial position?
Financial Position Analysis
Short Term Liabilities: OFIX's short term assets ($343.6M) exceed its short term liabilities ($89.6M).
Long Term Liabilities: OFIX's short term assets ($343.6M) exceed its long term liabilities ($161.1M).
Debt to Equity History and Analysis
Debt Level: OFIX's debt to equity ratio (29%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if OFIX's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable OFIX has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: OFIX is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 1.4% per year.
What is Orthofix Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OFIX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OFIX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OFIX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OFIX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OFIX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jon Serbousek (59 yo)
Mr. Jon C. Serbousek serves as President and Chief Executive Officer at Orthofix Medical Inc., since November 1, 2019 and served as its President of Global Spine since August 5, 2019 until November 1, 2019 ...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD5.28M) is above average for companies of similar size in the US market ($USD2.02M).
Compensation vs Earnings: Insufficient data to compare Jon's compensation with company performance.
|CFO & Chief Accounting Officer||5.42yrs||US$1.90m||0.23% |
|Chief Legal & Administrative Officer||2.92yrs||US$1.81m||0.092% |
|Chief Scientific Officer||7.17yrs||no data||no data|
|Chief Information Officer||3.67yrs||no data||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Chief Ethics & Compliance Officer||4.17yrs||no data||no data|
|President of Global Spine Business||0.75yr||no data||no data|
|Senior Director of Business Development & Investor Relations||no data||no data||no data|
Experienced Management: OFIX's management team is considered experienced (3.3 years average tenure).
|Independent Chairman||6.5yrs||US$485.02k||0.68% |
|Independent Director||5.25yrs||US$250.56k||0.057% |
|Independent Director||6.42yrs||US$274.98k||0.14% |
|Independent Director||3.75yrs||US$259.98k||0.0067% |
|Independent Director||0.25yr||no data||no data|
|Independent Director||2.5yrs||US$244.98k||0% |
|Independent Director||7.83yrs||US$254.98k||0.14% |
|Independent Director||4.5yrs||US$279.98k||0.026% |
Experienced Board: OFIX's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Orthofix Medical Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Orthofix Medical Inc.
- Ticker: OFIX
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$576.927m
- Shares outstanding: 19.33m
- Website: https://www.orthofix.com
Number of Employees
- Orthofix Medical Inc.
- 3451 Plano Parkway
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|OFIX||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Apr 1992|
|OM2||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Apr 1992|
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through two segments, Global Spine and Global Extremities. The Global Spine s ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/19 06:02|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.